Screeners
Heatmaps
Trends
News

You're viewing limited data.

Sign up

1 asset

Market news

TypeAll

SortNewest

Assets

PEPG

Type

TypeAll

All

Sort

SortNewest

Newest

Filter by asset

PepGen advances DM1 trial to highest dose cohort

Aug 6Investing.com

PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review

Aug 6Yahoo Finance

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

BOSTON, August 06, 2026--PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Aug 6Yahoo Finance

This is the newest page. Registered accounts read further back.